India to United States: Lansoprazole Export Trade Route

The India to United States Lansoprazole corridor is one of India's established pharmaceutical export routes, with 442 shipments documented worth a combined $47.1M USD. The route is dominated by PAR FORMULATIONS PRIVATE LIMITED, which alone accounts for roughly 34% of all export value, reflecting the consolidated nature of India's lansoprazole manufacturing sector.

Across 18 active suppliers, the average shipment value stands at $106.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with lansoprazole's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 31.8%, placing it at rank #9 among India's top lansoprazole export destinations globally.

On the import side, key buyers of Indian lansoprazole in United States include MYLAN PHARMACEUTICALS INC,, EVERSANA LIFE SCIENCE SERVICES, UPS SUPPLY CHAIN SOLUTIONS INC and 49 others. MYLAN PHARMACEUTICALS INC, is the single largest importer with 25 shipments valued at $11.6M USD.

India's lansoprazole exports to United States are driven primarily by a handful of large-scale manufacturers. PAR FORMULATIONS PRIVATE LIMITED with 80 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 18 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — PAR FORMULATIONS PRIVATE LIMITED, MYLAN LABORATORIES LIMITED, ZYDUS LIFESCIENCES LIMITED — together account for 71% of total trade value on this route. The average shipment value of $106.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as lansoprazole delayed-release orally disintegrating tablets 30 mg 100bl 5814 packs and lansoprazole dr od tab 30 mg - 10 x 10, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MYLAN PHARMACEUTICALS INC, is the largest importer with 25 shipments worth $11.6M USD — representing 25% of all lansoprazole imports from India on this route. A total of 52 buyers are active on this corridor.